XML 31 R38.htm IDEA: XBRL DOCUMENT v3.20.1
Equity Method Investments (Tables)
12 Months Ended
Dec. 31, 2019
Equity Method Investments And Joint Ventures [Abstract]  
Schedule of Equity Method Investments

Equity method investments as of December 31, 2019 and 2018 consisted of the following:

 

 

December 31,

 

 

2019

 

 

2018

 

 

Carrying

Value

 

 

Ownership

Percentage

 

 

Carrying

Value

 

 

Ownership

Percentage

 

 

(in thousands)

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

FF Gene Biotech

$

872

 

 

 

30

%

 

$

1,512

 

 

 

30

%

Total equity method investments

$

872

 

 

 

30

%

 

$

1,512

 

 

 

30

%

Summary of Financial Information for Equity Method Investees

Summary financial information for FF Gene Biotech is as follows:

 

 

December 31,

 

 

2019

 

 

2018

 

Consolidated Balance Sheet Data:

(in thousands)

 

Current assets

$

3,007

 

 

$

1,916

 

Non-current assets

$

4,457

 

 

$

4,068

 

Current liabilities

$

3,748

 

 

$

2,415

 

Non-current liabilities

$

889

 

 

$

 

Minority interest

$

(426

)

 

$

 

Stockholders' equity

$

3,253

 

 

$

3,569

 

 

 

Year Ended December 31,

 

 

2019

 

 

2018

 

Consolidated Statement of Operations Data:

(in thousands)

 

Net sales

$

4,055

 

 

$

1,254

 

Gross profit

$

1,354

 

 

$

67

 

Net loss

$

(3,009

)

 

$

(3,101

)

 

 

 

 

 

 

 

 

Share of loss from investments accounted for using the equity method

$

(777

)

 

$

(935

)